title: Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung.
abstract: Expression of human keratinocyte growth factor (KGF/FGF-7) was directed to epithelial cells of the developing embryonic lung of transgenic mice disrupting normal pulmonary morphogenesis during the pseudoglandular stage of development. By embryonic day 15.5(E15.5), lungs of transgenic surfactant protein C (SP-C)-KGF mice resembled those of humans with pulmonary cystadenoma. Lungs were cystic, filling the thoracic cavity, and were composed of numerous dilated saccules lined with glycogen-containing columnar epithelial cells. The normal distribution of SP-C proprotein in the distal regions of respiratory tubules was disrupted. Columnar epithelial cells lining the papillary structures stained variably and weakly for this distal respiratory cell marker. Mesenchymal components were preserved in the transgenic mouse lungs, yet the architectural relationship of the epithelium to the mesenchyme was altered. SP-C-KGF transgenic mice failed to survive gestation to term, dying before E17.5. Culturing mouse fetal lung explants in the presence of recombinant human KGF also disrupted branching morphogenesis and resulted in similar cystic malformation of the lung. Thus, it appears that precise temporal and spatial expression of KGF is likely to play a crucial role in the control of branching morphogenesis during fetal lung development.
authors.affiliation: Department of Developmental Biology, Amgen, Amgen Center, Thousand Oaks, CA 91320-1789, USA.
authors.forename: W S
authors.initials: WS
authors.lastname: Simonet
authors.forename: M L
authors.initials: ML
authors.lastname: DeRose
authors.forename: N
authors.initials: N
authors.lastname: Bucay
authors.forename: H Q
authors.initials: HQ
authors.lastname: Nguyen
authors.forename: S E
authors.initials: SE
authors.lastname: Wert
authors.forename: L
authors.initials: L
authors.lastname: Zhou
authors.forename: T R
authors.initials: TR
authors.lastname: Ulich
authors.forename: A
authors.initials: A
authors.lastname: Thomason
authors.forename: D M
authors.initials: DM
authors.lastname: Danilenko
authors.forename: J A
authors.initials: JA
authors.lastname: Whitsett
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000032:analysis; D003537:Cystadenoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D005314:Embryonic and Fetal Development; D005313:Fetal Death; D051526:Fibroblast Growth Factor 10; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors; D005865:Gestational Age; D006133:Growth Substances / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D008168:Lung / Q000196:embryology* / Q000473:pathology; D008175:Lung Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D011401:Promoter Regions, Genetic; D011510:Proteolipids / Q000235:genetics; D011663:Pulmonary Surfactants / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis
chemical_list: D015415:Biomarkers; C496453:FGF7 protein, human; C496454:Fgf7 protein, mouse; D051526:Fibroblast Growth Factor 10; D006133:Growth Substances; D011510:Proteolipids; D011663:Pulmonary Surfactants; D012333:RNA, Messenger; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors